Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Endothelioma, Vascular

paclitaxel has been researched along with Endothelioma, Vascular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glass, LF; Jukic, DM; McNab, PM; Quigley, BC1
Fukao, T; Funato, M; Hirose, Y; Hori, T; Kanda, K; Kaneko, H; Kondo, N; Mizuta, K; Ozeki, M; Sasai, H; Terazawa, D1

Reviews

2 review(s) available for paclitaxel and Endothelioma, Vascular

ArticleYear
Composite hemangioendothelioma and its classification as a low-grade malignancy.
    The American Journal of dermatopathology, 2013, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Biopsy; Child; Drug Administration Schedule; Female; Hemangioendothelioma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Grading; Neoplasms, Complex and Mixed; Paclitaxel; Predictive Value of Tests; Skin Neoplasms; Terminology as Topic; Treatment Outcome; Young Adult

2013
Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature.
    Head & neck, 2013, Volume: 35, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Child; Head and Neck Neoplasms; Hemangioendothelioma; Humans; Kasabach-Merritt Syndrome; Lung Neoplasms; Male; Paclitaxel; Sarcoma, Kaposi

2013